Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs —Boehringer taps RetinAI for AI boost to eye disease R&D—Big pharma holds steady on research spending-- See more on our front page news http://bit.ly/w28kSd #researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Roche, Boehringer tap biosensor firms for patient studies — FDA advisers back Cidara and Melinta’s antifungal treatment — EMA validates Vertex's CRISPR application, clearing barrier on road to landmark approval -- See more on our front page news http://bit.ly/w28kSd #roche #boehringeringelheim #biosensors #fda #antifungals #crispr #sicklecell #sicklecelldisease #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#roche #boehringeringelheim #biosensors #FdA #antifungals #crispr #sicklecell #Sicklecelldisease #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
Pfizer pledges to sell all of its products at cost to poor countries — Boehringer, Takeda make it into global top 15 employer list — Medtech approvals stagnate -- See more on our front page news http://bit.ly/w28kSd #pfizer #boehringeringelheim #takeda #topemployers2023 #medtech #deviceapprovals #fda #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#pfizer #boehringeringelheim #takeda #topemployers2023 #medtech #deviceapprovals #FdA #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma